Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
Clinical trial NCT06109441 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06109441
- Sponsor
- AltruBio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2026-03-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.